Canada Spends Logo

Explore our Budget 2026 analysis

Grant: Alliance Grants

Dalhousie University

$38,222.00

Practical and Sustainable Catalytic Synthesis of Heteroatom-Rich Molecules of Pharmaceutical Relevance

FY 2024-25

Summary
The discovery and efficient production of active pharmaceutical ingredients (APIs) is central to the development of new and societally important medicines. In this process, synthetic chemists require efficient methods of preparing structurally complex organic molecules that contain not just carbon and hydrogen atoms, but other elements (i.e., 'heteroatoms') including nitrogen, oxygen, sulfur, phosphorus, fluorine and beyond under mild, 'user-friendly' conditions. A powerful way to assemble such complex and otherwise difficult-to-make heteroatom-containing molecules involves the use of metal catalysts that allow smaller portions of targeted organic molecules to be systematically 'clipped together' in a process called cross-coupling, thereby allowing for the assembly of potential APIs in a streamlined and cost-effective manner. This collaborative research project springboards off of a successful collaborative partnership between the Stradiotto group at Dalhousie University (with expertise in sustainable cross-coupling catalysis) and the industrial partner (Paraza Pharma Inc., Montreal, QC) with regard to addressing specific unmet synthetic chemistry challenges faced by Paraza Pharma Inc. with regard to the targeted synthesis and/or modification of heteroatom-dense compounds within proprietary APIs. A key facet of this proposed research relates to the specific need of the industrial partner to develop cost-effective and efficient synthetic chemistry methodologies that make use of cheap and abundant reaction partners (e.g., heteroaryl chlorides), as well as Earth abundant catalysts based on nickel (rather than precious metal catalysts based on palladium that are used widely in such applications currently). Access to such new synthetic protocols will accelerate and render more sustainable and cost-effective a range of proprietary API synthesis and functionalization programs ongoing at Paraza Pharma Inc., thereby leading to more rapid discovery of new medicines for the benefit of all Canadians.
Program
Alliance Grants
Location
Nova Scotia, Canada
Recipient Type
Academia
Type
Grant
Source
NSERC's Awards Data

As published

Application id
596200-2024
Name nom
Stradiotto, Mark MJ
Department département
Chemistry
Organization id
79
Institution établissement
Dalhousie University
Province en
Nova Scotia
Province fr
Nouvelle-Écosse
Country en
CANADA
Country fr
CANADA
Fiscal year exercice financier
2024
Competition year année de concours
2024
Award amount
38222
Program id
ALLRP
Program name en
Alliance Grants
Program name fr
Subventions Alliance
Group en
RESEARCH PARTNERSHIPS
Group fr
PARTENARIATS DE RECHERCHE
Committee code
96
Committee name en
RPP Internal Decision Cttee
Committee name fr
Cté de décision interne - PPR
Area of application code
504
Area of application group en
Manufacturing processes and products
Area of application group fr
Procédés et produits industriels
Area of application en
Human pharmaceuticals
Area of application fr
Produits pharmaceutiques administrables à l'homme
Research subject code
3704
Research subject group en
Organic chemistry
Research subject group fr
Chimie organique
Research subject en
Synthetic methodology
Research subject fr
Méthodologie en synthèse
Field of research list names en
Not available
Field of research list names fr
Non disponible
Socioeconomic objective list names en
Not available
Socioeconomic objective list names fr
Non disponible
Application title
Practical and Sustainable Catalytic Synthesis of Heteroatom-Rich Molecules of Pharmaceutical Relevance
Keywords
catalysis; cross-coupling; nickel; organic chemistry; organometallic chemistry; pharmaceuticals; sustainability; synthetic methodology
Application summary
The discovery and efficient production of active pharmaceutical ingredients (APIs) is central to the development of new and societally important medicines. In this process, synthetic chemists require efficient methods of preparing structurally complex organic molecules that contain not just carbon and hydrogen atoms, but other elements (i.e., 'heteroatoms') including nitrogen, oxygen, sulfur, phosphorus, fluorine and beyond under mild, 'user-friendly' conditions. A powerful way to assemble such complex and otherwise difficult-to-make heteroatom-containing molecules involves the use of metal catalysts that allow smaller portions of targeted organic molecules to be systematically 'clipped together' in a process called cross-coupling, thereby allowing for the assembly of potential APIs in a streamlined and cost-effective manner. This collaborative research project springboards off of a successful collaborative partnership between the Stradiotto group at Dalhousie University (with expertise in sustainable cross-coupling catalysis) and the industrial partner (Paraza Pharma Inc., Montreal, QC) with regard to addressing specific unmet synthetic chemistry challenges faced by Paraza Pharma Inc. with regard to the targeted synthesis and/or modification of heteroatom-dense compounds within proprietary APIs. A key facet of this proposed research relates to the specific need of the industrial partner to develop cost-effective and efficient synthetic chemistry methodologies that make use of cheap and abundant reaction partners (e.g., heteroaryl chlorides), as well as Earth abundant catalysts based on nickel (rather than precious metal catalysts based on palladium that are used widely in such applications currently). Access to such new synthetic protocols will accelerate and render more sustainable and cost-effective a range of proprietary API synthesis and functionalization programs ongoing at Paraza Pharma Inc., thereby leading to more rapid discovery of new medicines for the benefit of all Canadians.
Dalhousie University - $38,222 Grant (2024-25) | Canada Spends